Chronic Kidney Disease (CKD) Surveillance Project

Chronic Kidney Disease (CKD) Surveillance Project





More Laboratories Are Routinely Reporting eGFR



In the United States, 30 million adults are estimated to have chronic kidney disease (CKD), and most are not aware of their condition.¹ Blood tests that measure creatinine are used to estimate glomerular filtration rate (eGFR) or the level of kidney function. Together with urine tests, eGFR is used to identify people with CKD. All clinical laboratories are recommended to report eGFR based on measured creatinine. A clinical laboratory testing survey of 5,183 laboratories from the College of American Pathologists shows that automated eGFR reporting for adults with every creatinine measure has increased nearly fourfold over the past 14 years, from 23% in 2003 to 86% in 2017. In 2017, 13% of laboratories did not automatically report eGFR, but rather reported when requested or at some other frequency. Reporting of eGFR, rather than creatinine alone, helps the provider to identify people with CKD and guide patient care and management. See the Chronic Kidney Disease Surveillance website to find out more about laboratory reporting of eGFR.

¹Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet, 2017. Atlanta, GA: US Department of Health and Human Services; 2017.